LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said FDA has approved Incruse Ellipta, or umeclidinium, as treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema. Umeclidinium is GSK's first once-daily an Read More
LONDON (Alliance News) - The FTSE 100 closed marginally higher Wednesday, adding to gains posted on Monday and Tuesday, and ensuring that the blue-chip index closed the month of April firmly higher than it opened it. <br /><br />Meanwhile, it was a volatile day in the forex market following a Read More
LONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported a drop in revenue and net profit for the first quarter due to asset sales and a decline in sales of pharmaceuticals in the US, but the company also raised its dividend and reiterated its full-year profit guidance despite Read More
LONDON (Alliance News) - <strong>GlaxoSmithKline</strong> PLC Wednesday reported a drop in revenue and net profit for the first quarter due to asset sales and a decline in sales of pharmaceuticals in the US, but the company also raised its dividend and reiterated its full-year profit guidance Read More
LONDON (Alliance News) - US equities are set to open marginally lower Wednesday, as investors digest the latest tranche of quarterly trading statements released after the Wall Street close on Tuesday, and ahead of some important US macroeconomic data and the latest Federal Open Market Committee p Read More
LONDON (Alliance News) - Drugs giant GlaxoSmithKline PLC Wednesday reported a drop in revenue and net profit for the first quarter due to asset sales and a decline in sales of pharmaceuticals in the US, but the company also raised its dividend and reiterated its full-year profit guidance despite Read More
LONDON (Alliance News) - UK stocks trade mixed Wednesday, as investors await a raft of releases from the US and after the preliminary reading of eurozone consumer price inflation accelerated from a more than four-year low, but still missed forecasts. By mid-morning, the FTSE 100 is marginal Read More
(An item published at 0745 BST misstated the time GlaxoSmithKline is due to release its first-quarter results. The correct time follows.) Pharmaceutical giant GlaxoSmithKline is due to publish its first quarter results at 1100 GMT. By James Kemp; [email protected]; @jamespkem Read More
LONDON (Alliance News) - UK equities are set to open flat to slightly lower Wednesday, following some strong gains posted on Tuesday, as investors take their positions ahead of important macro economic releases from Europe and the US. Meanwhile, market participants in London face another da Read More
LONDON (Alliance News) - The FTSE 100 closed higher for the second day in a row Tuesday, ending the day at its highest closing level since March 6, buoyed in part by a strong performance by oil major BP and drugs company Shire.<br /><br />Meanwhile, it was a volatile day for the pound. Sterlin Read More
LONDON (Alliance News) - Respiratory treatment development company Vectura Group PLC Tuesday said it has triggered a GBP2 million milestone payment from GlaxoSmithKline PLC, a day after the drugs giant launched its chronic obstructive pulmonary disease treatment Anoro Ellipta in the US. Gla Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that its compound Incruse had been granted marketing authorisation by the European Commission as a treatment for chronic obstructive pulmonary disease. Glaxo expects the product to launch in Europe by the end of 2014. Incruse is Read More
LONDON (Alliance News) - GlaxoSmithKline PLC and Theravance Inc Monday launched their chronic obstructive pulmonary disease treatment Anoro Ellipta at retail pharmacies in the US. Under the terms of its agreement with Glaxo, Theravance has agreed to make a milestone payment of USD30 million Read More
LONDON (Alliance News) -<strong> AstraZeneca</strong> has led the FTSE 100 all Monday morning after US drugs giant Pfizer confirmed that it has now twice approached British peer with a takeover proposal.<br /><br />Pzifer said it is considering its options after being rebuffed for a second tim Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>AstraZeneca</strong>, up 15%. US drugs giant Pfizer Inc has confirmed that it has now t Read More
LONDON (Alliance News) - UK stocks indices are mixed Monday, with little in the economic calendar to provide direction and developments in Ukraine weighing on sentiment, but with a significant shot-in-the-arm provided by continued merger and and acquisition activity in the pharmaceutical sector.< Read More